Dihydromyricetin ameliorates experimental ulcerative colitis by inhibiting neutrophil extracellular traps formation via the HIF-1α/VEGFA signaling pathway
Article in International Immunopharmacology (July 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in International Immunopharmacology (July 2024)
Article in Biomedicine & Pharmacotherapy (May 2024)